Drug recall · July 13, 2016
MIDAZOLAM HCl in 0.9% Sodium Chloride Injection recall
Why: Subpotent Drug
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
MIDAZOLAM HCl in 0.9% Sodium Chloride Injection, 2 mg/2 mL (1 mg/mL), in 2 mL syringe, Rx only, Cantrell Drug Co., Little Rock, AR --- NDC 52533-001-16 UPC: 0100352533001161
- Lots / codes
Lot: 6178, exp, 9/12/15; 6529, exp 11/22/15
- Quantity
- 1570 syringes
- Company
- Cantrell Drug Company, Little Rock, AR
- Distribution
- Nationwide
- Initiated
- August 21, 2015 · Voluntary: Firm initiated
- Classified
- July 6, 2016
- Reported
- July 13, 2016
- Ended
- February 3, 2017
- How notified
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Midazolam
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.